Posted on March 25, 2021

(Nature Neuroscience, March 18, 2021) Cannabinoids reduce tremor associated with motor disorders induced by injuries and neurodegenerative disease. Here we show that this effect is mediated by cannabinoid receptors on astrocytes in the ventral horn of the spinal cord, where alternating limb movements are initiated. We first demonstrate that tremor is reduced in a mouse […]

Posted on March 8, 2021

Let’s Talk About ET; Share Some Facts About ET; Spread Awareness All Year with Our Special Tote Bags and Water Bottles; Tune into Our Podcast and Share it with Others.

Categories: Tremor Gram
Posted on March 8, 2021

Mark Honeyman went from being an only child to having 7 siblings and 37 nieces and nephews. Adopted at birth, he started a search for his birth parents several years ago to learn where his essential tremor came from. That led him on a journey with many twists and turns, and fascinating stories. He says […]

Categories: Podcasts

Shaky hands are not a sign of aging. And a shaky head is not a sure sign of Parkinson’s disease. An involuntary shaking of the hands, head, voice, legs or trunk can be a sign of essential tremor (ET). ET is one of the most common movement disorders in the world, and the most common […]

Categories: ET Awareness, ET News

I donated, for my first time, due to being an essential tremor (ET) patient myself and I see it as an opportunity to help others with ET by helping your organization in raising awareness. I have had ET since I was a child and now being 59 years old, I have seen how it affects […]

IETF: Past, Present and Future; Together We Can Make Life Better for People with ET; An Interview with Scholarship Recipient Madison Young.

Categories: Tremor Gram

By Richard Riehl,Freelance Writer Today I agreed to donate my brain to medical science. (I’ll pause here to allow regular readers of my published opinion pieces to stop laughing.) Twenty-two years ago, after an afternoon of heavy yard work, I reached for a cold beer and sat down to rest. As I brought the bottle […]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Biogen Inc. (Nasdaq: BIIB) and Sage Therapeutics, Inc. (Nasdaq: SAGE) announced that they have executed a global collaboration and license agreement to jointly develop and commercialize zuranolone (SAGE-217) for major depressive disorder (MDD), postpartum depression (PPD) and other psychiatric disorders and SAGE-324 for essential tremor and other neurological disorders.